中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02627 中慧生物-B

交易中 02-03 15:31:42

47.040

+0.940

+2.04%

最高47.480	最低46.000	成交量16.14万
今开46.000	昨收46.100	日振幅3.21%
总市值184.87亿	流通市值139.41亿	总股本3.93亿
成交额754.92万	换手率0.05%	流通股本2.96亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02627","market":"HK","secType":"STK","nameCN":"中慧生物-B","latestPrice":47.04,"timestamp":1770103691341,"preClose":46.1,"halted":0,"volume":161400,"delay":0,"changeRate":0.020390455531453314,"floatShares":296361845,"shares":393000000,"eps":-0.71,"marketStatus":"交易中","change":0.94,"latestTime":"02-03 15:31:42","open":46,"high":47.48,"low":46,"amount":7549196,"amplitude":0.032104,"askPrice":47.32,"askSize":600,"bidPrice":47,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":-0.625,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770106200000},"marketStatusCode":2,"adr":0,"listingDate":1754841600000,"exchange":"SEHK","adjPreClose":46.1,"openAndCloseTimeList":[[1770082200000,1770091200000],[1770094800000,1770105600000]],"volumeRatio":0.606146,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02627","defaultTab":"news","newsList":[{"id":"2607018352","title":"中慧生物-B(02627)：三价流感病毒亚单位疫苗的上市申请获国家药监局批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2607018352","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607018352?lang=zh_cn&edition=full","pubTime":"2026-01-30 16:54","pubTimestamp":1769763288,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B(02627)发布公告，中国国家药品监督管理局已批准本集团针对所有年龄组别的三价流感病毒亚单位疫苗的新药申请。截至本公告日期，该款疫苗成为中国首款且唯一一款获批上市的全人群全剂量三价流感病毒亚单位疫苗。该产品在传统病毒裂解疫苗的基础上进行重大升级，具有保护全面、组分抗原纯度高、不良反应风险低等优势。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1399791.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["159646","02627","BK1161"],"gpt_icon":0},{"id":"2607508350","title":"中慧生物-B盘中异动 股价大跌5.07%报48.700港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607508350","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607508350?lang=zh_cn&edition=full","pubTime":"2026-01-29 13:58","pubTimestamp":1769666280,"startTime":"0","endTime":"0","summary":"2026年01月29日下午盘13时58分，中慧生物-B股票出现异动，股价急速下跌5.07%。截至发稿，该股报48.700港元/股，成交量22.42万股，换手率0.08%，振幅5.56%。资金方面，该股资金流入630.403万港元，流出447.172万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。中慧生物-B股票所在的生物技术行业中，整体跌幅为0.63%。中慧生物-B公司简介：江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012913580097a3e9ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012913580097a3e9ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2606278203","title":"中慧生物-B01月27日获主力加仓169.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606278203","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606278203?lang=zh_cn&edition=full","pubTime":"2026-01-27 16:15","pubTimestamp":1769501755,"startTime":"0","endTime":"0","summary":"01月27日, 中慧生物-B股价涨0.90%，报收50.35元，成交金额765.3万元，换手率0.05%，振幅5.33%，量比0.64。中慧生物-B今日主力资金净流入169.3万元，连续3日净流入，上一交易日主力净流入255.4万元。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为42.86%，平均涨幅为2.94%。该股近5个交易日上涨5.42%，主力资金累计净流入644.5万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2748.7万元，其中净流入天数为11日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162338a6b2240b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260127162338a6b2240b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2606278717","title":"中慧生物-B盘中异动 早盘急速跳水5.08%报48.600港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606278717","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606278717?lang=zh_cn&edition=full","pubTime":"2026-01-26 10:35","pubTimestamp":1769394935,"startTime":"0","endTime":"0","summary":"2026年01月26日早盘10时35分，中慧生物-B股票出现异动，股价大幅下跌5.08%。截至发稿，该股报48.600港元/股，成交量10.3万股，换手率0.03%，振幅5.66%。资金方面，该股资金流入331.102万港元，流出164.402万港元。中慧生物-B股票所在的生物技术行业中，整体跌幅为2.35%。中慧生物-B公司简介：江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610353597a356e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012610353597a356e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2604153919","title":"中慧生物-B01月19日主力净流出198.7万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2604153919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604153919?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:15","pubTimestamp":1768810539,"startTime":"0","endTime":"0","summary":"01月19日, 中慧生物-B股价跌3.15%，报收48.86元，成交金额2025.1万元，换手率0.14%，振幅11.99%，量比1.12。中慧生物-B今日主力资金净流出198.7万元，上一交易日主力净流入252.3万元。该股近5个交易日上涨20.40%，主力资金累计净流入51.6万元；近20日主力资金累计净流入2867.6万元，其中净流入天数为12日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162037a43c0d05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260119162037a43c0d05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2603614819","title":"中慧生物-B01月16日主力净流入252.3万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2603614819","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603614819?lang=zh_cn&edition=full","pubTime":"2026-01-16 16:16","pubTimestamp":1768551363,"startTime":"0","endTime":"0","summary":"01月16日, 中慧生物-B股价涨7.52%，报收50.45元，成交金额3259.6万元，换手率0.22%，振幅8.84%，量比2.40。中慧生物-B今日主力资金净流入252.3万元，上一交易日主力净流出2.0万元。该股近5个交易日上涨23.17%，主力资金累计净流入250.2万元；近20日主力资金累计净流入3090.1万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162423a4cb2a6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116162423a4cb2a6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2603067635","title":"国海证券：首予中慧生物-B(02627)“增持”评级 慧尔康欣正处快速放量通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2603067635","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603067635?lang=zh_cn&edition=full","pubTime":"2026-01-15 14:20","pubTimestamp":1768458038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国海证券发布研报称，首次覆盖，给予中慧生物-B“增持”评级，预测公司有望在2027年实现盈利，迎来业绩与估值双重提升的“戴维斯双击”。慧尔康欣是国内首款且唯一的四价亚单位流感疫苗，相比于裂解疫苗，具有保护全面、组分抗原纯度高、不良反应风险低等优势。作为公司首款获批产品，正处快速放量通道，引领流感疫苗消费升级。2025年12月其Ⅲ期临床试验已启动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393208.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","000750"],"gpt_icon":0},{"id":"2603675140","title":"港股异动 | 中慧生物-B(02627)涨超7% 国内流感疫苗潜在增长空间广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2603675140","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603675140?lang=zh_cn&edition=full","pubTime":"2026-01-15 14:14","pubTimestamp":1768457662,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中慧生物-B涨超7%，截至发稿，涨7.54%，报46.5港元，成交额1884.16万港元。消息面上，国家卫生健康委近日召开2026年首场新闻发布会，专家建议，所有6月龄以上没有疫苗接种禁忌证的人群每年都应该接种流感疫苗。国海证券指，慧尔康欣是国内首款且唯一的四价亚单位流感疫苗，相比于裂解疫苗，具有保护全面、组分抗原纯度高、不良反应风险低等优势。作为公司首款获批产品，正处快速放量通道，引领流感疫苗消费升级。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2603858622","title":"中慧生物-B盘中异动 早盘快速拉升5.13%报45.460港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2603858622","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603858622?lang=zh_cn&edition=full","pubTime":"2026-01-15 09:54","pubTimestamp":1768442054,"startTime":"0","endTime":"0","summary":"2026年01月15日早盘09时54分，中慧生物-B股票出现波动，股价快速上涨5.13%。截至发稿，该股报45.460港元/股，成交量13万股，换手率0.04%，振幅4.16%。中慧生物-B股票所在的生物技术行业中，整体涨幅为0.60%。其相关个股中，东曜药业-B、中慧生物-B、维立志博-B涨幅较大，振幅较大的相关个股有晶泰控股、永泰生物-B、华生物-B，振幅分别为7.73%、6.45%、5.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011509541497a1de2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011509541497a1de2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2602901725","title":"中慧生物-B(02627)：程千文辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2602901725","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602901725?lang=zh_cn&edition=full","pubTime":"2026-01-12 17:13","pubTimestamp":1768209203,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B(02627)发布公告，程千文先生(程先生)因希望投放更多时间于自身的其他个人事务上，故程先生已向董事会呈辞本公司非执行董事及董事会审计委员会成员职务。董事会宣布，张阳阳女士(张女士)因希望投放更多时间于自身的其他个人事务上，故张女士已向董事会呈辞本公司董事会秘书兼联席公司秘书(联席公司秘书)职务，自2026年1月12日起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391642.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2601848509","title":"中慧生物-B01月06日主力净流入67.2万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2601848509","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601848509?lang=zh_cn&edition=full","pubTime":"2026-01-06 16:15","pubTimestamp":1767687308,"startTime":"0","endTime":"0","summary":"01月06日, 中慧生物-B股价涨1.23%，报收41.20元，成交金额802.0万元，换手率0.07%，振幅3.29%，量比0.91。中慧生物-B今日主力资金净流入67.2万元，上一交易日主力净流出0万元。该股近5个交易日上涨2.74%，主力资金累计净流入1454.2万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4412.4万元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161526a6f96e26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106161526a6f96e26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2600064155","title":"中慧生物-B01月02日获主力加仓464.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600064155","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600064155?lang=zh_cn&edition=full","pubTime":"2026-01-02 16:15","pubTimestamp":1767341733,"startTime":"0","endTime":"0","summary":"01月02日，中慧生物-B股价收平报40.24元，成交金额668.3万元，换手率0.06%，振幅2.24%，量比0.68。中慧生物-B今日主力资金净流入464.1万元，连续4日净流入，上一交易日主力净流入472.1万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为60.00%，平均涨幅为1.75%。该股近5个交易日下跌1.32%，主力资金累计净流入1569.8万元；近20日主力资金累计净流入5071.5万元，其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161704a49420cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102161704a49420cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2600705856","title":"中慧生物-B12月31日获主力加仓344.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2600705856","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600705856?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:16","pubTimestamp":1767168963,"startTime":"0","endTime":"0","summary":"12月31日, 中慧生物-B股价涨0.55%，报收40.24元，成交金额666.4万元，换手率0.06%，振幅1.40%，量比0.77。中慧生物-B今日主力资金净流入344.6万元，连续4日净流入，上一交易日主力净流入472.1万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为40.00%，平均涨幅为2.30%。该股近5个交易日下跌1.32%，主力资金累计净流入1450.3万元；近20日主力资金累计净流入4952.0万元，其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231162312a48dba32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231162312a48dba32&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2593499067","title":"中慧生物-B(02627)：李建军获选为独立非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2593499067","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593499067?lang=zh_cn&edition=full","pubTime":"2025-12-23 18:31","pubTimestamp":1766485908,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B(02627)发布公告，有关委任李建军先生为公司独立非执行董事的建议决议案已于临时股东会上获正式通过。根据公司的章程，李先生已获选为董事会独立非执行董事。上述委任李先生后，董事会亦欣然宣布，自2025年12月23日临时股东会结束起，李先生已获委任为董事会审计委员会主席及董事会薪酬与考核委员会成员;于建林先生不再担任董事会提名委员会成员;李润香女士已获委任为董事会提名委员会成员;及陈乘贝先生已获委任为董事会提名委员会成员。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385016.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2593952944","title":"中慧生物-B12月23日主力净流入182.8万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2593952944","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593952944?lang=zh_cn&edition=full","pubTime":"2025-12-23 16:15","pubTimestamp":1766477726,"startTime":"0","endTime":"0","summary":"12月23日，中慧生物-B股价收平报40.78元，成交金额826.3万元，换手率0.07%，振幅2.21%，量比1.20。中慧生物-B今日主力资金净流入182.8万元，上一交易日主力净流出0万元。该股近5个交易日上涨0.30%，主力资金累计净流入555.9万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入4239.7万元，其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161658a6c5094c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223161658a6c5094c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2592160438","title":"中慧生物-B12月19日获主力加仓120.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592160438","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592160438?lang=zh_cn&edition=full","pubTime":"2025-12-19 16:16","pubTimestamp":1766132163,"startTime":"0","endTime":"0","summary":"12月19日, 中慧生物-B股价涨0.54%，报收40.82元，成交金额652.3万元，换手率0.05%，振幅2.32%，量比0.94。中慧生物-B今日主力资金净流入120.5万元，连续6日净流入，上一交易日主力净流入141.0万元。该股近5个交易日下跌0.29%，主力资金累计净流入676.0万元；近20日主力资金累计净流入4281.2万元，其中净流入天数为18日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162252a45f26da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251219162252a45f26da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2592491725","title":"中慧生物-B12月17日获主力加仓111.5万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2592491725","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592491725?lang=zh_cn&edition=full","pubTime":"2025-12-17 16:15","pubTimestamp":1765959357,"startTime":"0","endTime":"0","summary":"12月17日, 中慧生物-B股价涨0.15%，报收40.72元，成交金额764.9万元，换手率0.06%，振幅2.21%，量比1.06。中慧生物-B今日主力资金净流入111.5万元，连续4日净流入，上一交易日主力净流入279.0万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为25.00%，平均涨幅为0.99%。该股近5个交易日上涨1.54%，主力资金累计净流入577.3万元，其中3个交易日为股价下跌时净流入；近20日主力资金累计净流入4055.9万元，其中净流入天数为17日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162210a456041c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217162210a456041c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02627","BK1161"],"gpt_icon":0},{"id":"2589352213","title":"中慧生物-B(02627)：冻干人用狂犬病疫苗(人二倍体细胞)的III期临床试验启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2589352213","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589352213?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:13","pubTimestamp":1765185186,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B 发布公告，集团近期启动集团冻干人用狂犬病疫苗的III期临床试验。公司于2024年10月完成该在研疫苗的I期临床试验。狂犬病是由一种狂犬病病毒引起的严重病毒性疾病，可能导致意识模糊和渐进性瘫痪等严重症状。利用人二倍体细胞研制的狂犬病疫苗为世卫组织推荐的“金标准”狂犬病疫苗，具有强大的安全性。公司的在研狂犬病疫苗在已完成的I期临床试验中显示出良好的安全性特征。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378825.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4134","III","159646","02627","BK1161"],"gpt_icon":0},{"id":"2588804788","title":"中慧生物-B(02627)提名李建军为独立非执行董事候选人","url":"https://stock-news.laohu8.com/highlight/detail?id=2588804788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588804788?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:19","pubTimestamp":1764857965,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中慧生物-B(02627)公布，李晓青女士因欲投入更多时间于个人的其他事务，已向董事会辞任公司独立非执行董事、董事会审计委员会主席、董事会薪酬与考核委员会成员及董事会提名委员会成员职务。此外，李建军先生已获提名担任董事会第二届独立非执行董事候选人，惟须待公司临时股东会审议及批准后方始作实。李建军先生已获委任为董事会审计委员会主席及董事会薪酬与考核委员会成员，而于建林先生不再担任董事会提名委员会成员，李润香女士则已获委任为董事会提名委员会成员及陈乘贝先生获委任为董事会提名委员会成员，全部均自李建军先生于临时股东会获选为公司独立非执行董事之日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377908.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02627"],"gpt_icon":0},{"id":"2588077396","title":"突破！慧尔康欣首次出口澳门——四价流感病毒亚单位疫苗助力澳门地区健康防护","url":"https://stock-news.laohu8.com/highlight/detail?id=2588077396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588077396?lang=zh_cn&edition=full","pubTime":"2025-12-04 11:48","pubTimestamp":1764820082,"startTime":"0","endTime":"0","summary":"国际化战略迈出关键一步近日，中慧生物-B自主研发的四价流感病毒亚单位疫苗——慧尔康欣顺利运抵澳门特别行政区并完成通关，成功实现首次出口，正式进入澳门市场。当前正值流感季，澳门特别行政区持续加强呼吸道传染病防控。本次疫苗的及时引入，将为澳门居民提供优质、可靠的免疫选择，助力当地筑牢公共卫生防线。首针仪式顺利举行，携手共建健康澳门12月4日，该疫苗在澳门银葵医院成功举行首针接种仪式。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1377608.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","02627","BK1161"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abbbio.com","stockEarnings":[{"period":"1week","weight":-0.0762},{"period":"1month","weight":0.1456},{"period":"3month","weight":0.1462},{"period":"6month","weight":2.5736},{"period":"ytd","weight":0.1456}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0166},{"period":"3month","weight":0.0317},{"period":"6month","weight":0.0749},{"period":"1year","weight":0.3239},{"period":"ytd","weight":0.0447}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏中慧元通生物科技股份有限公司是一家主要从事疫苗的研发、制造及商业化中国公司。该公司的产品管线包括两种核心产品，即四价流感病毒亚单位疫苗及在研冻干人用狂犬病疫苗，以及其他11种在研疫苗。该公司主要在中国市场开展业务。","exchange":"SEHK","name":"中慧生物-B","nameEN":"AB&B BIO-TECH-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中慧生物-B,02627,中慧生物-B股票,中慧生物-B股票老虎,中慧生物-B股票老虎国际,中慧生物-B行情,中慧生物-B股票行情,中慧生物-B股价,中慧生物-B股市,中慧生物-B股票价格,中慧生物-B股票交易,中慧生物-B股票购买,中慧生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中慧生物-B(02627)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中慧生物-B(02627)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}